STEMRIM |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 411 JPY | +0.49% |
|
-12.55% | -28.89% |
| May. 09 | StemRIM to Seek Shareholders' Approval on Capital Stock Reduction | MT |
| Mar. 13 | StemRIM Announces Initiation of Phase 2 Clinical Trial for Redasemtide in Ischemic Cardiomyopathy | CI |
- Stock Market
- Equities
- 4599 Stock
- News StemRIM
- Analyst Reco.
